Company / Operating Income
IMMUCELL CORP /DE/ Operating Income History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$1.6M
FY2025
5-year range
-$5.7M / $2.1M
FY2021-FY2025
Trend
+71.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income returned to growth in FY2025 after 3 years of decline, reaching -$2M.
Based on SEC 10-K filings.
-$2M in FY2025.
Improved from -$2M to -$2M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 71.5% year-over-year.
- Peak operating income was recorded in FY2016.
- Lowest operating income in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.6M | +71.5% |
| FY2024 | -$5.7M | -150.0% |
| FY2023 | -$2.3M | -358.2% |
| FY2017 | $890.2K | -58.1% |
| FY2016 | $2.1M | +10954.8% |
| FY2015 | -$19.6K | -108.0% |
| FY2014 | $245.0K | +138.7% |
| FY2013 | -$632.7K | +8.3% |
| FY2012 | -$690.3K | -30.3% |
| FY2011 | -$529.9K | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026